Trials / Completed
CompletedNCT00215358
Study in Patients With Asthma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 32 (planned)
- Sponsor
- Dey · Industry
- Sex
- All
- Age
- 12 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Formoterol Fumarate |
Timeline
- Start date
- 2002-07-01
- Primary completion
- 2002-10-01
- Completion
- 2005-12-01
- First posted
- 2005-09-22
- Last updated
- 2010-11-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00215358. Inclusion in this directory is not an endorsement.